Vecuronium Bromide: Clinical Trials

17 trials of Vecuronium Bromide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 4 unknown, 1 not yet recruiting, 1 recruiting. 10 Phase 4, 2 Not applicable, 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 410Completed 6, Unknown 4
Not applicable2Completed 1, Recruiting 1
Phase 22Completed 1, Not yet recruiting 1
Phase 32Completed 2

Follow Vecuronium Bromide: new trials by email Literature Review of Vecuronium Bromide trials Research Report on Vecuronium Bromide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Dose-Finding Study of Amogammadex Sodium for Reversing Vecuronium and Rocuronium-Induced Neuromuscular Blockade
Rocuronium (0.6mg/kg), vecuronium bromide (0.1mg/kg) - Reversing Vecuronium-Induced Neuromuscular Blockade in Patients Undergoing General Anesthesia Surgery, Reversing Rocuronium-Induced Neuromuscular Blockade in Patients Undergoing General Anesthesia Surgery
Phase 2Not yet recruitingAmckaus PTY LTD.642026-08-012026-05-19
Effect of Opioid-Free vs Opioid-Based Anesthesia on Postoperative Pain and Emergence Agitation in Children Undergoing Cleft Surgery
Ketamine (1 mg/kg), Dexmedetomidine (1-0,8-0,6-0,4 mcg/kg/h), Fentanyl 5 mcg/kg - Cleft Lip Palate, Orofacial Cleft
Not applicableRecruitingIva Smiljanić902024-05-162026-04-29
Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome
protective ventilation, prone position ventilation, glucocorticoid therapy - Acute Respiratory Distress Syndrome
Phase 4UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine10002022-10-012022-12-21
Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146)
Sugammadex 2 mg/kg ABW, Sugammadex 2 mg/kg IBW, Sugammadex 4 mg/kg ABW - Neuromuscular Blockade
Phase 4CompletedMerck Sharp & Dohme LLC2072018-01-012021-01-28
Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)
Sugammadex 2 mg/kg, Sugammadex 4 mg/kg, Sugammadex 16 mg/kg - Reversal of Neuromuscular Blockade
Phase 4CompletedMerck Sharp & Dohme LLC3442017-12-202020-10-08
Evaluation of Atracurium-vecuronium Combination in Laparosocpic Surgery
Vecuronium, Atracurium, Vecuronium + Atracurium - Patients Undergoing Laparoscopic Surgery
Phase 4UnknownSir Ganga Ram Hospital482017-12-202017-12-14
Does Deep Neuromuscular Blockade Improve Operating Conditions During Total Hip Replacements?
Vecuronium 0.1 mg/kg, Vecuronium 0.2mg/kg - Arthropathy of Hip
Phase 4CompletedCraig Curry1162017-05-012019-09-18
Opioid-Free Shoulder Arthroplasty
Gabapentin, Celecoxib, toradol - Opioid Use, Shoulder Osteoarthritis
Phase 4CompletedOrthoCarolina Research Institute, Inc.862016-09-012020-10-14
Intraoperative Lidocaine Infusion vs. Esmolol Infusion for Postoperative Analgesia in Laparoscopic Cholecystectomy
Lidocaine, Esmolol, Paracetamol - Gall Stone Disease
Phase 4CompletedB.P. Koirala Institute of Health Sciences902015-01-012018-11-30
Mask Ventilation Before and After Neuromuscular Blockade
Rocuronium, Vecuronium Bromide, Succinylcholine - Anesthesia
Phase 4CompletedUniversity of Washington2102014-08-012015-04-09
Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients
Induction of anesthesia,midazolam ,sufentanil,etomidate and rocuronium, Dexmedetomidine, Normal saline - Postoperative Confusion
Phase 4UnknownTang-Du Hospital1202014-07-012014-07-11
The Effect of TEAS on the Quality of Early Recovery
TEAS, Con, propofol, remifentanil, vecuronium - C.Delivery; Surgery (Previous), Gynecological, Inappropriate Device Stimulation of Tissue
Not applicableCompletedGuizhou Provincial People's Hospital602013-11-012015-12-02
A Study of Residual Curarization Incidence in China
Vecuronium Bromide, Rocuronium, Cisatracurium - Perioperative/Postoperative Complications, PORC (Postoperative Residual Curarization)
Phase 4UnknownPeking University First Hospital60902012-10-012013-05-24
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care: - Adenovirus, Anesthesia
CompletedDaniel Benjamin35202011-11-012023-09-06
Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025)
sugammadex, neostigmine, vecuronium - Anesthesia, General
Phase 3CompletedMerck Sharp & Dohme LLC1822005-11-282019-03-19
A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part B: Caucasian Participants (P05971)
Sugammadex, Placebo, Rocuronium - Anesthesia, General
Phase 2CompletedMerck Sharp & Dohme LLC1002005-09-202019-11-25
Comparative Study of Rocuronium With Vecuronium (Study 71101)(COMPLETED)
Rocuronium 0.6 mg/kg intubating dose, Rocuronium 0.9 mg/kg intubating dose, Rocuronium 0.1 mg/kg maintenance dose - Anesthesia
Phase 3CompletedMerck Sharp & Dohme LLC902003-02-012015-04-17

Conditions studied

Arrhythmias, Cardiac (2)  ·  Bradycardia (2)  ·  Delayed Emergence from Anesthesia (2)  ·  Adenoviridae Infections (1)  ·  Agnosia (1)  ·  Anxiety Disorders (1)  ·  Arthritis (1)  ·  Autistic Disorder (1)  ·  Bipolar Disorder (1)  ·  Central Nervous System Infections (1)  ·  Cytomegalovirus Retinitis (1)  ·  Emergence Delirium (1)  ·  Endocarditis (1)  ·  Epilepsy (1)  ·  Headache (1)

Sponsors

Merck Sharp & Dohme LLC (5)  ·  Amckaus PTY LTD. (1)  ·  B.P. Koirala Institute of Health Sciences (1)  ·  Craig Curry (1)  ·  Daniel Benjamin (1)  ·  Guizhou Provincial People's Hospital (1)  ·  Iva Smiljanić (1)  ·  OrthoCarolina Research Institute, Inc. (1)  ·  Peking University First Hospital (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Sir Ganga Ram Hospital (1)  ·  Tang-Du Hospital (1)  ·  University of Washington (1)

Countries

United States (6)  ·  Austria (2)  ·  China (2)  ·  Denmark (2)  ·  Germany (2)  ·  Belgium (1)  ·  Canada (1)  ·  Croatia (1)  ·  India (1)  ·  Israel (1)  ·  Nepal (1)  ·  Singapore (1)  ·  United Kingdom (1)

Top investigators

Aaron M Joffe, DO (1)  ·  Amitabh Dutta, MD,PGDHR (1)  ·  Asish Subedi, MD (1)  ·  Chi Hornik, PharmD (1)  ·  Craig Curry, MD (1)  ·  Iva Smiljanic, MD, MSc (1)  ·  Savitar Malhotra, MD (1)  ·  Subhash Gupta, MD (1)  ·  Xinmin Wu, Doctor (1)  ·  Zhaocai Zhang, Doctor (1)

Results publications

PMID 18946293, PMID 20809967, PMID 20876699, PMID 24614374, PMID 24949994, PMID 26039810, PMID 26444853, PMID 26926644, PMID 27522443, PMID 28137820, PMID 28290120, PMID 28779462, PMID 29084742, PMID 29271816, PMID 29435949, PMID 29677389, PMID 30790601, PMID 31317556, PMID 31548185, PMID 31684867, PMID 31814149, PMID 31915045, PMID 32324313, PMID 32497307, PMID 33029806, PMID 33639839, PMID 33903114, PMID 34302290, PMID 34711192, PMID 35370711, PMID 35491971, PMID 41247430

NIH funding

2017 (2), 2005 (1)